Global Gout Therapeutics Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1660

Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries.
Increased research and development in the field has yielded significantly more effective medications in the recent times, which are recommended to patients on the basis of severity of the condition. Introduction of urate-lowering agents is one of the primary driver of the gout therapeutics market. First line therapies such as Febuxostat and Allopurinol are now replaced urate-lowering agents such as Lesinurad, which help in reducing pain as well as negotiate the risk of joint destruction. The growing popularity of OTC drugs such as Oral colchicine, corticosteroids, and NASAIDs, which are quite effective in moderate gout indications, are also favoring the global gout therapeutics market in the positive direction. Technological advancements in medical imaging is another factor augmenting the demand in the gout therapeutics market. On the other hand, low levels of physician and patient awareness, heavy dependency on generic drugs, and use of CAM for the treatment of gout are restraining factors over the global gout therapeutics market.
At present, the Americas is the largest market for gout therapeutics and is estimated to retain its hold over the market until the end of 2020. The market in this region is growing briskly due to the higher incidences of gout in the US, which results in the growing consumption of gout drugs. In this region, novel therapies like llaris and lesinurad FDC are expected to launch during the forecast period in the US as they have proven benefits over the standard of care. This indicates that novel therapies will have a favorable market potential and good market success during the forecast period.
In 2018, the global Gout Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Gout Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gout Therapeutics development in United States, Europe and China.

The key players covered in this study
Takeda Pharmaceutical Company
Novartis
AstraZeneca
GlaxoSmithKline
Merck
Regeneron Pharmaceuticals
...

Market segment by Type, the product can be split into
NSAIDs
Corticosteroids
Colchicine
Urate-Lowering Agents

Market segment by Application, split into
Acute Gout
Chronic Gout

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Gout Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Gout Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gout Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gout Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 NSAIDs
1.4.3 Corticosteroids
1.4.4 Colchicine
1.4.5 Urate-Lowering Agents
1.5 Market by Application
1.5.1 Global Gout Therapeutics Market Share by Application (2014-2025)
1.5.2 Acute Gout
1.5.3 Chronic Gout
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Gout Therapeutics Market Size
2.2 Gout Therapeutics Growth Trends by Regions
2.2.1 Gout Therapeutics Market Size by Regions (2014-2025)
2.2.2 Gout Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Gout Therapeutics Market Size by Manufacturers
3.1.1 Global Gout Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Gout Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Gout Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Gout Therapeutics Key Players Head office and Area Served
3.3 Key Players Gout Therapeutics Product/Solution/Service
3.4 Date of Enter into Gout Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gout Therapeutics Market Size by Type (2014-2019)
4.2 Global Gout Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Gout Therapeutics Market Size (2014-2019)
5.2 Gout Therapeutics Key Players in United States
5.3 United States Gout Therapeutics Market Size by Type
5.4 United States Gout Therapeutics Market Size by Application

6 Europe
6.1 Europe Gout Therapeutics Market Size (2014-2019)
6.2 Gout Therapeutics Key Players in Europe
6.3 Europe Gout Therapeutics Market Size by Type
6.4 Europe Gout Therapeutics Market Size by Application

7 China
7.1 China Gout Therapeutics Market Size (2014-2019)
7.2 Gout Therapeutics Key Players in China
7.3 China Gout Therapeutics Market Size by Type
7.4 China Gout Therapeutics Market Size by Application

8 Japan
8.1 Japan Gout Therapeutics Market Size (2014-2019)
8.2 Gout Therapeutics Key Players in Japan
8.3 Japan Gout Therapeutics Market Size by Type
8.4 Japan Gout Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Gout Therapeutics Market Size (2014-2019)
9.2 Gout Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Gout Therapeutics Market Size by Type
9.4 Southeast Asia Gout Therapeutics Market Size by Application

10 India
10.1 India Gout Therapeutics Market Size (2014-2019)
10.2 Gout Therapeutics Key Players in India
10.3 India Gout Therapeutics Market Size by Type
10.4 India Gout Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Gout Therapeutics Market Size (2014-2019)
11.2 Gout Therapeutics Key Players in Central & South America
11.3 Central & South America Gout Therapeutics Market Size by Type
11.4 Central & South America Gout Therapeutics Market Size by Application

12 International Players Profiles
12.1 Takeda Pharmaceutical Company
12.1.1 Takeda Pharmaceutical Company Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gout Therapeutics Introduction
12.1.4 Takeda Pharmaceutical Company Revenue in Gout Therapeutics Business (2014-2019)
12.1.5 Takeda Pharmaceutical Company Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gout Therapeutics Introduction
12.2.4 Novartis Revenue in Gout Therapeutics Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gout Therapeutics Introduction
12.3.4 AstraZeneca Revenue in Gout Therapeutics Business (2014-2019)
12.3.5 AstraZeneca Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gout Therapeutics Introduction
12.4.4 GlaxoSmithKline Revenue in Gout Therapeutics Business (2014-2019)
12.4.5 GlaxoSmithKline Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gout Therapeutics Introduction
12.5.4 Merck Revenue in Gout Therapeutics Business (2014-2019)
12.5.5 Merck Recent Development
12.6 Regeneron Pharmaceuticals
12.6.1 Regeneron Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Gout Therapeutics Introduction
12.6.4 Regeneron Pharmaceuticals Revenue in Gout Therapeutics Business (2014-2019)
12.6.5 Regeneron Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details